FindTrial
Sign In

Construction and verification of Chinese medicine syndrome differentiation diagnostic criteria for early breast cancer

Construction and verification of Chinese medicine syndrome differentiation diagnostic criteria for early breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006139
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Case collection:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1)Patients whose pathology meets the diagnostic criteria of early breast cancer (stage I-III, excluding distant metastasis); (2)Female patients over 18 years old (including 18 years old); (3)Patients with a score of 0-2 in ECOG (Eastern Cooperative Oncology Group); (4)Patients who voluntarily participated in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1)Serious accompanying diseases such as cardio-cerebrovascular or psychological disease; (2)Receiving the neoadjuvant, or receiving the chemotherapy, radiotherapy, or endocrine treatment simultaneously; (3)Complications of breast cancer treatment, such as postoperative wound infection, severe lymphoedema, neutropenic fever or radiation pneumonia; (4) Pregnant or breastfeeding participants.

Design outcomes

Primary

MeasureTime frame
Signs and symptoms, Chinese medicine syndromes and Chinese herbal formulas.;—

Countries

China

Contacts

Public ContactQianjun Chen
cqj55@163.com18688883505

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026